Similar Articles

Home | Newsletter | My Articles | My Account | Help

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool June 9, 2011 Brian Orelli	Get Out of Here! $0.5 Million to License a Drug? Somaxon licenses rights to Silenor in Canada, South America, and Africa to Paladin.
The Motley Fool August 25, 2010 Brian Orelli	Shares Soar! That'll Help Investors Sleep Better Tonight. Somaxon finds a marketing partner for its insomnia drug.
The Motley Fool November 1, 2010 Sean Williams	Somaxon Pharmaceuticals: Bargain or Value Trap? A strong balance sheet and Procter & Gamble could make this a value play.
The Motley Fool July 28, 2010 Jordan DiPietro	3 Biotechs on Your Radar Screen It's not easy keeping track of all the drugs coming in and out of the development pipeline, but if you can stay up to date, you often have an advantage
The Motley Fool July 27, 2010 Anand Chokkavelu	5 Stocks to Buy Before Apple Consider these five first.